SANA - Sana Biotechnology, Inc. Common Stock

Day 1m 10m 60m PreMarket Market AfterHours Gap
--- --- --- --- --- --- --- ---

Sana Biotechnology Inc is a biotechnology company. The company develops engineered cells as medicines and therapies to treat diseases. It is engaged in developing cell engineering programs for across a broad array of therapeutic areas with unmet treatment needs, including oncology, diabetes, B-cell-mediated autoimmune, and central nervous system (CNS) disorders, among others. Its pipeline of product candidates is comprised of SC291, SC262, SC255, UP421 and others.

Category: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
Market Period: PreMarket

Earnings & Ratios

Basic EPS:
-0.39
Diluted EPS:
-0.39
Basic P/E:
Diluted P/E:
RSI(14) 1m:
42.75
VWAP:
5.3
RVol:

Events

Period Kind Movement Occurred At

Related News